DHG Pharmaceutical Joint Stock Company at its board meeting held on December 2, 2022 approved CEO Changes. Masashi Nakaura resigned as General Director (CEO), Legal Representative with effect from December 31, 2022. Toshiyuki Ishii appointed as General Director (CEO), Legal Representative with effect from January 1, 2023.

Appointment term is from January 1, 2023 to December 31, 2025.